
News|Articles|October 28, 2024
ICP-MS and ICP-OES: Tools for Elemental Impurity Analysis
Author(s)Alcami
Elemental impurity testing is essential to deliver safe drug products to patients and is a regulatory requirement. It is important to assess the risk of elemental impurities from all sources in the manufacturing process, including process equipment, water, container/packaging, raw materials, drug substances, and the final drug product.
Trending on Pharmaceutical Technology
1
PharmTech Weekly Roundup—June 5, 2026
2
EMA Collaborates with African Regulators on Ebola Treatments
3
A Pharma Manufacturing Blueprint from Delaware’s Innovation Vision
4
Faster Doesn’t Mean Easier: Development Impacts of a New Biosimilar Regulatory Landscape
5